Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAMOND: Patiromer for Hyperkalemia in Heart Failure
NCT03888066Phase 3Completed
- Sponsor
- Vifor Pharma
- Start
- Apr 2019
- Primary completion
- Sep 2021
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of patiromer in hyperkalemia, sponsored by Vifor Pharma. Started Apr 2019; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT03888066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03888066.